Quentin Calonge
YOU?
Author Swipe
View article: Comparing three natural language processing methods for the automatic identification of epilepsy patients from French clinical notes
Comparing three natural language processing methods for the automatic identification of epilepsy patients from French clinical notes Open
Objective Manual review of clinical notes by experts remains the reference standard for identifying patients with epilepsy in health databases. However, this process is labor‐intensive and time‐consuming due to the unstructured nature of t…
View article: Incidence, mortality, and management of status epilepticus from 2012 to 2022: An 11‐year nationwide study
Incidence, mortality, and management of status epilepticus from 2012 to 2022: An 11‐year nationwide study Open
Objective Recent data on status epilepticus (SE) incidence and mortality remain limited, despite the 2015 revision of its definition by the International League Against Epilepsy. The impact of the COVID‐19 pandemic also remains unclear. We…
View article: Recurrence and Mortality After a First Status Epilepticus
Recurrence and Mortality After a First Status Epilepticus Open
Our study highlights a high risk of recurrence or death within 3 years after a first SE. We identified factors associated with increased risk of both recurrence and mortality and factors specifically associated with recurrence or mortality…
View article: Updated Multiple Sclerosis Incidence in France, 2011–2021
Updated Multiple Sclerosis Incidence in France, 2011–2021 Open
This study provides a comprehensive analysis of MS epidemiology in France, demonstrating stable incidence and sex ratio. The increase in prevalence suggests improved management and survival and highlights the ongoing need for health care s…
View article: Time Trends in Incidence of Motor Neuron Diseases in France: A Comprehensive 14‐Year Nationwide Study (2010–2023)
Time Trends in Incidence of Motor Neuron Diseases in France: A Comprehensive 14‐Year Nationwide Study (2010–2023) Open
Background Changes over time in the incidence of Motor Neuron Disease (MND) remain uncertain. We aimed to examine time trends in the incidence and survival of MND over 14 years using the Système National des Données de Santé, a nationwide …
View article: How Reliable Is the G41 Discharge Code for Status Epilepticus?
How Reliable Is the G41 Discharge Code for Status Epilepticus? Open
Introduction Medico‐administrative databases are increasingly used to study the epidemiology of status epilepticus (SE), targeting hospitalizations with the SE G41 ICD‐10 code. However, the positive predictive value (PPV) of the G41 code, …
View article: Cannabidiol Treatment for Adult Patients with Drug‐Resistant Epilepsies: A Real‐World Study in a Tertiary Center
Cannabidiol Treatment for Adult Patients with Drug‐Resistant Epilepsies: A Real‐World Study in a Tertiary Center Open
Background and purpose Around 30% of patients with epilepsy show drug‐resistant epilepsy (DRE). While cannabidiol has demonstrated efficacy as an adjunctive treatment in Dravet syndrome (DS), Lennox–Gastaut Syndrome (LGS), and epilepsy rel…